{
    "info": {
        "nct_id": "NCT04269213",
        "official_title": "A Phase II Study of CPX-351 in Younger Patients &lt; 60 Years Old With Secondary Acute Myeloid Leukemia",
        "inclusion_criteria": "* Newly diagnosed:\n\n  * Therapy-related acute myeloid leukemia (AML)\n  * AML with antecedent myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML)\n  * AML with MDS-related changes (as per World Health Organization [WHO])\n* Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2\n* Plasma creatinine =< 1.5 x upper limit of normal (ULN)\n* Total bilirubin < 2.0 mg/dL\n* Serum alanine aminotransferase and aspartate aminotransferase < 3 x ULN\n* Left ventricular ejection fraction by echocardiogram or multiple-gated acquisition >= 50%\n* Participants of child-bearing potential must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately\n* Women of childbearing potential must have a negative serum or urine pregnancy test within 72 hours prior to enrollment and commit to two forms of birth control\n* Men must use a latex condom during any sexual contact with women of childbearing potential\n* Willing to adhere to protocol specific requirements\n* Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 59 Years",
        "exclusion_criteria": "* Prior treatment of AML\n* Known clinically active central nervous system (CNS) leukemia\n* Core-binding factor leukemia\n* Acute promyelocytic leukemia\n* Uncontrolled other malignancy\n* Prior anthracycline exposure > 368 mg/m^2 of daunorubicin or equivalent\n* Cardiovascular disease resulting in heart failure (New York Heart Association class III or IV), unstable angina (angina symptoms at rest), or new onset angina (began within the last 3 months) or myocardial infarction within the past 6 months\n* Hypersensitivity to cytarabine, daunorubicin, or liposomal drugs\n* Known active HIV infection\n* Known history of active hepatitis B or C infection\n* Pre-existing liver disease (e.g. cirrhosis, chronic hepatitis B or C, nonalcoholic steatohepatitis, sclerosing cholangitis)\n* Evidence of ongoing, uncontrolled systemic infection\n* Pregnant or breastfeeding women\n* Subject with concurrent severe and/or uncontrolled medical or psychiatric conditions that in the opinion of the investigator may impair the participation in the study or the evaluation of safety and/or efficacy\n* History of Wilson disease or other copper-handling disorders\n* Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study drug",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of =< 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants of child-bearing potential must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately",
            "criterions": [
                {
                    "exact_snippets": "Participants of child-bearing potential must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry.",
                    "criterion": "child-bearing potential",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must agree to use adequate contraceptive methods (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry.",
                    "criterion": "contraceptive method use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing to adhere to protocol specific requirements",
            "criterions": [
                {
                    "exact_snippets": "Willing to adhere to protocol specific requirements",
                    "criterion": "willingness to adhere to protocol requirements",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum alanine aminotransferase and aspartate aminotransferase < 3 x ULN",
            "criterions": [
                {
                    "exact_snippets": "Serum alanine aminotransferase ... < 3 x ULN",
                    "criterion": "serum alanine aminotransferase",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "aspartate aminotransferase < 3 x ULN",
                    "criterion": "aspartate aminotransferase",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure",
            "criterions": [
                {
                    "exact_snippets": "Participant or legal representative must understand the investigational nature of this study",
                    "criterion": "understanding of investigational nature of study",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure",
                    "criterion": "signed informed consent form",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "approval",
                            "expected_value": [
                                "Independent Ethics Committee",
                                "Institutional Review Board"
                            ]
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to receiving any study related procedure"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Therapy-related acute myeloid leukemia (AML)",
            "criterions": [
                {
                    "exact_snippets": "Therapy-related acute myeloid leukemia (AML)",
                    "criterion": "therapy-related acute myeloid leukemia (AML)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AML with antecedent myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML)",
            "criterions": [
                {
                    "exact_snippets": "AML",
                    "criterion": "acute myeloid leukemia (AML)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "antecedent myelodysplastic syndrome (MDS)",
                    "criterion": "antecedent myelodysplastic syndrome (MDS)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic myelomonocytic leukemia (CMML)",
                    "criterion": "chronic myelomonocytic leukemia (CMML)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Plasma creatinine =< 1.5 x upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "Plasma creatinine =< 1.5 x upper limit of normal (ULN)",
                    "criterion": "plasma creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Newly diagnosed:",
            "criterions": [
                {
                    "exact_snippets": "Newly diagnosed",
                    "criterion": "diagnosis status",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": "newly diagnosed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 59 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 59 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 59,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Left ventricular ejection fraction by echocardiogram or multiple-gated acquisition >= 50%",
            "criterions": [
                {
                    "exact_snippets": "Left ventricular ejection fraction by echocardiogram or multiple-gated acquisition >= 50%",
                    "criterion": "left ventricular ejection fraction",
                    "requirements": [
                        {
                            "requirement_type": "measurement method",
                            "expected_value": [
                                "echocardiogram",
                                "multiple-gated acquisition"
                            ]
                        },
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Men must use a latex condom during any sexual contact with women of childbearing potential",
            "criterions": [
                {
                    "exact_snippets": "Men must use a latex condom during any sexual contact with women of childbearing potential",
                    "criterion": "condom use during sexual contact",
                    "requirements": [
                        {
                            "requirement_type": "material",
                            "expected_value": "latex"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "during any sexual contact with women of childbearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AML with MDS-related changes (as per World Health Organization [WHO])",
            "criterions": [
                {
                    "exact_snippets": "AML with MDS-related changes (as per World Health Organization [WHO])",
                    "criterion": "acute myeloid leukemia (AML) with myelodysplastic syndrome (MDS)-related changes",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "AML with MDS-related changes as per WHO"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential must have a negative serum or urine pregnancy test within 72 hours prior to enrollment and commit to two forms of birth control",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive status",
                            "expected_value": "childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative serum or urine pregnancy test within 72 hours prior to enrollment",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "serum pregnancy test",
                                "urine pregnancy test"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 72,
                                "unit": "hours prior to enrollment"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "commit to two forms of birth control",
                    "criterion": "birth control commitment",
                    "requirements": [
                        {
                            "requirement_type": "number of forms",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "forms"
                            }
                        },
                        {
                            "requirement_type": "commitment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin < 2.0 mg/dL",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin < 2.0 mg/dL",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 2.0,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* History of Wilson disease or other copper-handling disorders",
            "criterions": [
                {
                    "exact_snippets": "History of Wilson disease",
                    "criterion": "Wilson disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other copper-handling disorders",
                    "criterion": "copper-handling disorders",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known active HIV infection",
            "criterions": [
                {
                    "exact_snippets": "Known active HIV infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "awareness/status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Acute promyelocytic leukemia",
            "criterions": [
                {
                    "exact_snippets": "Acute promyelocytic leukemia",
                    "criterion": "acute promyelocytic leukemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled other malignancy",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled other malignancy",
                    "criterion": "other malignancy",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cardiovascular disease resulting in heart failure (New York Heart Association class III or IV), unstable angina (angina symptoms at rest), or new onset angina (began within the last 3 months) or myocardial infarction within the past 6 months",
            "criterions": [
                {
                    "exact_snippets": "Cardiovascular disease resulting in heart failure (New York Heart Association class III or IV)",
                    "criterion": "heart failure",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "New York Heart Association class III",
                                "New York Heart Association class IV"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina (angina symptoms at rest)",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "new onset angina (began within the last 3 months)",
                    "criterion": "new onset angina",
                    "requirements": [
                        {
                            "requirement_type": "onset_time",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "myocardial infarction within the past 6 months",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "event_time",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or breastfeeding women",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... women",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding women",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "breastfeeding",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment of AML",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment of AML",
                    "criterion": "prior treatment of AML",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject with concurrent severe and/or uncontrolled medical or psychiatric conditions that in the opinion of the investigator may impair the participation in the study or the evaluation of safety and/or efficacy",
            "criterions": [
                {
                    "exact_snippets": "concurrent severe and/or uncontrolled medical or psychiatric conditions",
                    "criterion": "medical or psychiatric conditions",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "in the opinion of the investigator may impair the participation in the study or the evaluation of safety and/or efficacy",
                    "criterion": "investigator opinion on impairment of participation or evaluation",
                    "requirements": [
                        {
                            "requirement_type": "investigator_opinion",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "impairment",
                            "expected_value": [
                                "participation in the study",
                                "evaluation of safety",
                                "evaluation of efficacy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pre-existing liver disease (e.g. cirrhosis, chronic hepatitis B or C, nonalcoholic steatohepatitis, sclerosing cholangitis)",
            "criterions": [
                {
                    "exact_snippets": "Pre-existing liver disease (e.g. cirrhosis, chronic hepatitis B or C, nonalcoholic steatohepatitis, sclerosing cholangitis)",
                    "criterion": "pre-existing liver disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cirrhosis",
                    "criterion": "cirrhosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic hepatitis B or C",
                    "criterion": "chronic hepatitis B",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic hepatitis B or C",
                    "criterion": "chronic hepatitis C",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "nonalcoholic steatohepatitis",
                    "criterion": "nonalcoholic steatohepatitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sclerosing cholangitis",
                    "criterion": "sclerosing cholangitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Core-binding factor leukemia",
            "criterions": [
                {
                    "exact_snippets": "Core-binding factor leukemia",
                    "criterion": "core-binding factor leukemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known clinically active central nervous system (CNS) leukemia",
            "criterions": [
                {
                    "exact_snippets": "Known clinically active central nervous system (CNS) leukemia",
                    "criterion": "central nervous system (CNS) leukemia",
                    "requirements": [
                        {
                            "requirement_type": "clinical activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "known diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study drug",
            "criterions": [
                {
                    "exact_snippets": "Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study drug",
                    "criterion": "any condition deemed unsuitable by investigator",
                    "requirements": [
                        {
                            "requirement_type": "investigator judgment of suitability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior anthracycline exposure > 368 mg/m^2 of daunorubicin or equivalent",
            "criterions": [
                {
                    "exact_snippets": "Prior anthracycline exposure > 368 mg/m^2 of daunorubicin or equivalent",
                    "criterion": "prior anthracycline exposure",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 368,
                                "unit": "mg/m^2 daunorubicin or equivalent"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of ongoing, uncontrolled systemic infection",
            "criterions": [
                {
                    "exact_snippets": "Evidence of ongoing, uncontrolled systemic infection",
                    "criterion": "systemic infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "ongoing status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Hypersensitivity to cytarabine, daunorubicin, or liposomal drugs",
            "criterions": [
                {
                    "exact_snippets": "Hypersensitivity to cytarabine",
                    "criterion": "hypersensitivity to cytarabine",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Hypersensitivity to daunorubicin",
                    "criterion": "hypersensitivity to daunorubicin",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Hypersensitivity to ... liposomal drugs",
                    "criterion": "hypersensitivity to liposomal drugs",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known history of active hepatitis B or C infection",
            "criterions": [
                {
                    "exact_snippets": "Known history of active hepatitis B",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known history of active hepatitis C infection",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}